Search by Drug Name or NDC

    NDC 00002-3182-61 Trulicity 4.5 mg/.5mL Details

    Trulicity 4.5 mg/.5mL

    Trulicity is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eli Lilly and Company. The primary component is DULAGLUTIDE.

    Product Information

    NDC 00002-3182
    Product ID 0002-3182_d89b25b3-0f8d-4cbd-b58b-44d112cd7fe6
    Associated GPIs 2717001500D250
    GCN Sequence Number 081454
    GCN Sequence Number Description dulaglutide PEN INJCTR 4.5 MG/0.5 SUBCUT
    HIC3 C4I
    HIC3 Description ANTIHYPERGLY,INCRETIN MIMETIC(GLP-1 RECEP.AGONIST)
    GCN 48573
    HICL Sequence Number 041421
    HICL Sequence Number Description DULAGLUTIDE
    Brand/Generic Brand
    Proprietary Name Trulicity
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dulaglutide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 4.5
    Active Ingredient Units mg/.5mL
    Substance Name DULAGLUTIDE
    Labeler Name Eli Lilly and Company
    Pharmaceutical Class GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA125469
    Listing Certified Through 2024-12-31

    Package

    NDC 00002-3182-61 (00002318261)

    NDC Package Code 0002-3182-61
    Billing NDC 00002318261
    Package 2 SYRINGE in 1 CARTON (0002-3182-61) / .5 mL in 1 SYRINGE
    Marketing Start Date 2020-09-30
    NDC Exclude Flag N
    Pricing Information N/A